Diabetes and Kidney Disease
This course will a comprehensive review of the management of diabetic kidney disease (DKD), including discussions of blood pressure control, new biomarkers and hypoglycemia agents on DKD development and progression.
Target Audience
Nephrologists, Emergency Medicine Physicians, Family Medicine Physicians, Internists, Hospitalists, Endocrinologists, Respiratory Therapists, Nurses, Nurse Practitioners and other interested healthcare professionals
Learning Objectives
• Summarize the guidelines for screening and management of diabetic kidney disease (DKD).
• Explain the contribution of blood pressure control with different agents on DKD development and progression.
• Describe how new biomarkers can help to stratify patients.
• Summarize the contribution of different hypoglycemia agents on DKD development and progression.
Alessia Fornoni, M.D., Ph.D.
Professor of Medicine
Chief, Katz Family Division of Nephrology and Hypertension
Director, Peggy and Harold Katz Family Drug Discovery Center
University of Miami
Miami, Florida
Alessia Fornoni, M.D., Ph.D., faculty for this educational activity, indicated that she has relevant financial relationships and nd has indicated that the presentation or discussion will not include off-label or unapproved product usage.
Grant/Research Support: Roche, Boehringer Ingelheim
Consultant: Variant Pharmaceutical, Ono, Pfeizer, Boehringer Ingelheim, AstraZeneca, Roche, Merck and Johnson and Johnson.
Stock Shareholder: Variant Pharmaceuticals
All of the relevant financial relationships listed for this individual has been mitigated.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Respiratory Therapy
Required Hardware/Software
PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| |||||||
Mobile UsersThis site is supported on the following mobile devices:
| |||||||
Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |